Fortis Healthcare Limited has announced its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The Board of Directors also recommended a final dividend of ₹1 per equity share (10% of face value) for the financial year 2025-26, subject to member approval. Additionally, the Company appointed M/s Jitender, Navneet & Co. as the Cost Auditor for the financial year 2026-27 and approved a Corporate Social Responsibility (CSR) Policy.

The financial performance for the quarter ended March 31, 2026, reflects a strong growth trajectory compared to both the previous quarter (Q3 FY26) and the corresponding quarter of the previous year (Q4 FY25). Consolidated revenue from operations reached ₹2,364.67 crore in Q4 FY26, showcasing a healthy increase. The comparative analysis of revenue and profit (based on consolidated results) is summarized below:

Note: The percentage calculations are derived from consolidated figures (in lacs) provided in the report, where ₹2,364.67 crore represents the current quarter. Previous quarter (Dec 31, 2025) revenue was ₹2,265.01 crore, and the corresponding quarter last year (Mar 31, 2025) was ₹2,007.20 crore.

Fortis Healthcare Limited is a leading integrated healthcare provider in India, operating an extensive network of hospitals, clinics, and diagnostic facilities. The company provides a wide range of services, including complex surgeries, critical care, and routine medical treatments, and its operations are primarily focused on specialties such as Cardiac, Orthopedics, Neurology, Gastroenterology, Oncology, and Renal Sciences. Recent updates from 2025-26 include the strategic acquisition of the People Tree Hospital in Bengaluru and Shrimann Hospital in Jalandhar to enhance its service footprint, alongside significant investments in high-value medical technology like soft tissue surgical robots, MRI machines, and PET CT scans. The hospital business remains the primary revenue driver, contributing approximately 85% to the total revenues. Major institutional investors in the company include HDFC Mutual Fund, Kotak Large & Midcap Fund, and Axis Mutual Fund.